A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis

S. Khatri; J. Hansen; M. H. Clausen; T. W. Kragstrup; S. C. Hung; E. Mellins; K. Astakhova

doi:10.1136/annrheumdis-2020-eular.6754

A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis

S. Khatri, J. Hansen, M. H. Clausen, T. W. Kragstrup, S. C. Hung, E. Mellins, K. Astakhova

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

Original language	English
Article number	LB0002
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue	Suppl.1
Pages (from-to)	208
Number of pages	1
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2020-eular.6754
Publication status	Published - 2020
Event	Annual European Congress of Rheumatology (EULAR) - Duration: 3 Jun 2020 → …

Conference

Conference	Annual European Congress of Rheumatology (EULAR)
Period	03/06/2020 → …

Access to Document

10.1136/annrheumdis-2020-eular.6754

Cite this

Khatri, S., Hansen, J., Clausen, M. H., Kragstrup, T. W., Hung, S. C., Mellins, E., & Astakhova, K. (2020). A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis. Annals of the Rheumatic Diseases, 79(Suppl.1), 208. Article LB0002. https://doi.org/10.1136/annrheumdis-2020-eular.6754

@article{5e594f36dd924f798d3a4c0c8465895b,

title = "A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis",

author = "S. Khatri and J. Hansen and Clausen, {M. H.} and Kragstrup, {T. W.} and Hung, {S. C.} and E. Mellins and K. Astakhova",

year = "2020",

doi = "10.1136/annrheumdis-2020-eular.6754",

language = "English",

volume = "79",

pages = "208",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "Suppl.1",

note = "Annual European Congress of Rheumatology (EULAR) ; Conference date: 03-06-2020",

}

Khatri, S, Hansen, J, Clausen, MH, Kragstrup, TW, Hung, SC, Mellins, E & Astakhova, K 2020, 'A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis', Annals of the Rheumatic Diseases, vol. 79, no. Suppl.1, LB0002, pp. 208. https://doi.org/10.1136/annrheumdis-2020-eular.6754

A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis. / Khatri, S.; Hansen, J.; Clausen, M. H. et al.
In: Annals of the Rheumatic Diseases, Vol. 79, No. Suppl.1, LB0002, 2020, p. 208.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - A first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis

AU - Khatri, S.

AU - Hansen, J.

AU - Clausen, M. H.

AU - Kragstrup, T. W.

AU - Hung, S. C.

AU - Mellins, E.

AU - Astakhova, K.

PY - 2020

Y1 - 2020

U2 - 10.1136/annrheumdis-2020-eular.6754

DO - 10.1136/annrheumdis-2020-eular.6754

M3 - Conference abstract in journal

SN - 0003-4967

VL - 79

SP - 208

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl.1

M1 - LB0002

T2 - Annual European Congress of Rheumatology (EULAR)

Y2 - 3 June 2020

ER -